Page last updated: 2024-09-03

astragaloside a and Acute Brain Injuries

astragaloside a has been researched along with Acute Brain Injuries in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's5 (71.43)2.80

Authors

AuthorsStudies
Ding, Z; He, Y; Lin, B; Wan, H; Wei, X; Yang, J; Yin, J; Zhou, H1
Chen, L; Cui, G; He, J; Huan, Q; Lu, Z; Shi, Z; Wang, Y; Xu, Q; Zhang, C1
Chen, J; Chen, L; Han, Y; Hu, X; Miao, H; Ou, Z; Wang, Y; Yao, J1
Dong, X; Yang, L; Zhang, W1
Chu, L; Fang, Y; Gan, H; Hu, X; Jin, H; Li, L; Yang, Y; Zhang, J1
Ammar, AB; Guo, S; Hong, Y; Shao, A; Tang, J; Tu, S; Wu, H; Zhang, J1
Chang, CK; Chang, CP; Chiu, BY; Hsu, YC; Lin, JW; Yang, ST1

Other Studies

7 other study(ies) available for astragaloside a and Acute Brain Injuries

ArticleYear
Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats.
    Food & function, 2023, Apr-24, Volume: 14, Issue:8

    Topics: Animals; Biomarkers; Brain Injuries; Brain Ischemia; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; Metabolomics; Proteomics; Rats; Rats, Sprague-Dawley; Transcriptome

2023
Astragaloside IV alleviates stroke-triggered early brain injury by modulating neuroinflammation and ferroptosis via the Nrf2/HO-1 signaling pathway.
    Acta cirurgica brasileira, 2023, Volume: 38

    Topics: Animals; Brain Injuries; Cytokines; Ferroptosis; Infarction; Neuroinflammatory Diseases; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Signal Transduction; Stroke

2023
Astragaloside IV promotes angiogenesis by targeting SIRT7/VEGFA signaling pathway to improve brain injury after cerebral infarction in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 168

    Topics: Animals; Brain Injuries; Brain Ischemia; Infarction, Middle Cerebral Artery; Molecular Docking Simulation; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Sirtuins

2023
Astragaloside IV alleviates the brain damage induced by subarachnoid hemorrhage via PI3K/Akt signaling pathway.
    Neuroscience letters, 2020, 09-14, Volume: 735

    Topics: Animals; Brain Edema; Brain Injuries; Dose-Response Relationship, Drug; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Saponins; Signal Transduction; Subarachnoid Hemorrhage; Triterpenes

2020
Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARĪ³ pathway after cerebral ischemia/reperfusion injury in rats.
    International immunopharmacology, 2021, Volume: 92

    Topics: Animals; Brain Injuries; Cell Polarity; Disease Models, Animal; Infarction, Middle Cerebral Artery; Macrophages; Male; Microglia; Neovascularization, Physiologic; Neurogenesis; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Triterpenes

2021
Astragaloside IV alleviates early brain injury following experimental subarachnoid hemorrhage in rats.
    International journal of medical sciences, 2014, Volume: 11, Issue:10

    Topics: Animals; Brain Injuries; Male; Rats; Rats, Sprague-Dawley; Saponins; Subarachnoid Hemorrhage; Triterpenes

2014
Astragaloside improves outcomes of traumatic brain injury in rats by reducing microglia activation.
    The American journal of Chinese medicine, 2014, Volume: 42, Issue:6

    Topics: Animals; Apoptosis; Brain; Brain Injuries; Disease Models, Animal; Drugs, Chinese Herbal; Injections, Intraperitoneal; Male; Microglia; Motor Activity; Phytotherapy; Rats, Sprague-Dawley; Saponins; Triterpenes; Tumor Necrosis Factor-alpha

2014